| Year |
Citation |
Score |
| 2022 |
Chiang CL, Hu EY, Chang L, Labanowska J, Zapolnik K, Mo X, Shi J, Doong TJ, Lozanski A, Yan PS, Bundschuh R, Walker LA, Gallego-Perez D, Lu W, Long M, et al. Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity. Cell Reports. 40: 111115. PMID 35858552 DOI: 10.1016/j.celrep.2022.111115 |
0.336 |
|
| 2021 |
Saygin C, Hu E, Zhang P, Sher S, Lozanski A, Doong TJ, Nicolet D, Orwick S, Labanowska J, Skinner JN, Cempre C, Kauffman T, Goettl VM, Heerema NA, Abruzzo L, et al. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq. Leukemia. PMID 34021247 DOI: 10.1038/s41375-021-01295-1 |
0.452 |
|
| 2020 |
Hu EY, Blachly JS, Saygin C, Ozer HG, Workman SE, Lozanski A, Doong TJ, Chiang CL, Bhat S, Rogers KA, Woyach JA, Coombes KR, Jones D, Muthusamy N, Lozanski G, et al. LC-FACSeq is a method for detecting rare clones in leukemia. Jci Insight. 5. PMID 32554930 DOI: 10.1172/Jci.Insight.134973 |
0.397 |
|
| 2020 |
Lucas F, Larkin K, Gregory CT, Orwick S, Doong TJ, Lozanski A, Lozanski G, Misra S, Ngankeu A, Ozer HG, Sampath D, Thangavadivel S, Yilmaz AS, Rogers KA, Byrd J, et al. Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations. Blood. PMID 32232486 DOI: 10.1182/Blood.2019003722 |
0.453 |
|
| 2019 |
Woyach J, Huang Y, Rogers K, Bhat SA, Grever MR, Lozanski A, Doong T, Blachly JS, Lozanski G, Jones D, Byrd JC. Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations Blood. 134: 504-504. DOI: 10.1182/Blood-2019-127674 |
0.434 |
|
| 2019 |
Hu E, Ozer HG, Lozanski A, Doong T, Chiang C, Bhat SA, Rogers KA, Woyach J, Blachly JS, Lozanski G, Muthusamy N, Byrd JC. LC-Facseq: A Novel Method for Detecting Rare Resistant Clones in Leukemia Blood. 134: 3377-3377. DOI: 10.1182/Blood-2019-126070 |
0.4 |
|
| 2017 |
Woyach JA, Ruppert AS, Guinn D, Lehman A, Blachly JS, Lozanski A, Heerema NA, Zhao W, Coleman J, Jones D, Abruzzo L, Gordon A, Mantel R, Smith LL, McWhorter S, ... ... Doong TJ, et al. BTK(C481S)-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016702282. PMID 28418267 DOI: 10.1200/Jco.2016.70.2282 |
0.471 |
|
| 2016 |
Woyach JA, Guinn D, Ruppert AS, Blachly JS, Lozanski A, Heerema NA, Zhao W, Coleman J, Jones D, Abruzzo LV, Gordon A, Mantel R, Smith LL, McWhorter S, Davis M, ... Doong T, et al. the Development and Expansion of Resistant Subclones Precedes Relapse during Ibrutinib Therapy in Patients with CLL Blood. 128: 55-55. DOI: 10.1182/Blood.V128.22.55.55 |
0.491 |
|
| Show low-probability matches. |